Merck (MRK) Cash & Current Investments (2009 - 2026)
Merck (MRK) reported Cash & Current Investments of $5.7 billion for Q1 2026, down 38.21% year-over-year from $9.2 billion in Q1 2025, and down 60.85% on a QoQ basis from $14.6 billion in Q4 2025.
Merck (MRK) has 18 years of Cash & Current Investments data on file, last reported at $5.7 billion in Q1 2026.
- Quarterly Cash & Current Investments fell 38.21% year-over-year to $5.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 billion (down 38.21% YoY) and the FY2025 annual result came in at $14.6 billion, up 6.4% from the prior year.
- Cash & Current Investments slipped to $5.7 billion in Q1 2026 per MRK's latest filing, from $14.6 billion in the prior quarter.
- Across five years, Cash & Current Investments topped out at $18.2 billion in Q3 2025 and bottomed at $5.6 billion in Q1 2024.
- The 5-year median for Cash & Current Investments is $10.1 billion (2022), against an average of $10.5 billion.
- The widest annual swing landed in 2023, when Cash & Current Investments tumbled 46.23%; it then surged 92.99% in 2024.
- Tracing MRK's Cash & Current Investments over 5 years: stood at $13.2 billion in 2022, then plunged by 46.23% to $7.1 billion in 2023, then jumped by 92.99% to $13.7 billion in 2024, then gained by 6.4% to $14.6 billion in 2025, then plunged by 60.85% to $5.7 billion in 2026.
- Per Business Quant, the three latest MRK Cash & Current Investments figures stand at $5.7 billion (Q1 2026), $14.6 billion (Q4 2025), and $18.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 9.39 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 5.70 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 7.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 13.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 10.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.70 Bn |
| Dec 31, 2025 | 14.57 Bn |
| Sep 30, 2025 | 18.21 Bn |
| Jun 30, 2025 | 8.62 Bn |
| Mar 31, 2025 | 9.23 Bn |
| Dec 31, 2024 | 13.69 Bn |
| Sep 30, 2024 | 14.59 Bn |
| Jun 30, 2024 | 11.35 Bn |
| Mar 31, 2024 | 5.62 Bn |
| Dec 31, 2023 | 7.09 Bn |
| Sep 30, 2023 | 8.77 Bn |
| Jun 30, 2023 | 6.38 Bn |
| Mar 31, 2023 | 10.39 Bn |
| Dec 31, 2022 | 13.19 Bn |
| Sep 30, 2022 | 11.25 Bn |
| Jun 30, 2022 | 10.13 Bn |
| Mar 31, 2022 | 8.93 Bn |
| Dec 31, 2021 | 8.10 Bn |
| Sep 30, 2021 | 10.02 Bn |
| Jun 30, 2021 | 8.58 Bn |
| Mar 31, 2021 | 6.98 Bn |
| Dec 31, 2020 | 8.05 Bn |
| Sep 30, 2020 | 7.36 Bn |
| Jun 30, 2020 | 11.10 Bn |
| Mar 31, 2020 | 7.43 Bn |
| Dec 31, 2019 | 10.45 Bn |
| Sep 30, 2019 | 8.02 Bn |
| Jun 30, 2019 | 7.11 Bn |
| Mar 31, 2019 | 8.80 Bn |
| Dec 31, 2018 | 8.86 Bn |
| Sep 30, 2018 | 10.29 Bn |
| Jun 30, 2018 | 7.59 Bn |
| Mar 31, 2018 | 7.35 Bn |
| Dec 31, 2017 | 8.50 Bn |
| Sep 30, 2017 | 16.30 Bn |
| Jun 30, 2017 | 14.07 Bn |
| Mar 31, 2017 | 14.64 Bn |
| Dec 31, 2016 | 14.34 Bn |
| Sep 30, 2016 | 13.07 Bn |
| Jun 30, 2016 | 11.83 Bn |
| Mar 31, 2016 | 12.94 Bn |
| Dec 31, 2015 | 13.43 Bn |
| Sep 30, 2015 | 12.09 Bn |
| Jun 30, 2015 | 11.37 Bn |
| Mar 31, 2015 | 15.60 Bn |
| Dec 31, 2014 | 15.72 Bn |
| Sep 30, 2014 | 14.35 Bn |
| Jun 30, 2014 | 13.40 Bn |
| Mar 31, 2014 | 20.51 Bn |
| Dec 31, 2013 | 17.49 Bn |
| Sep 30, 2013 | 18.17 Bn |
| Jun 30, 2013 | 18.10 Bn |
| Mar 31, 2013 | 13.02 Bn |
| Dec 31, 2012 | 16.14 Bn |
| Sep 30, 2012 | 17.36 Bn |
| Jun 30, 2012 | 17.45 Bn |
| Mar 31, 2012 | 15.57 Bn |
| Dec 31, 2011 | 14.97 Bn |
| Sep 30, 2011 | 14.62 Bn |
| Jun 30, 2011 | 13.98 Bn |
| Mar 31, 2011 | 13.03 Bn |
| Dec 31, 2010 | 12.20 Bn |
| Sep 30, 2010 | 10.62 Bn |
| Jun 30, 2010 | 9.94 Bn |
| Mar 31, 2010 | 9.78 Bn |
| Dec 31, 2009 | 9.60 Bn |
| Sep 30, 2009 | 22.30 Bn |
| Jun 30, 2009 | 13.87 Bn |
| Mar 31, 2009 | 6.02 Bn |